^
+ Follow PIOGLITAZONE Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 783179
                    [Title] => Initial results show NASH improved with vitamin E
                    [Summary] => 

The use of vitamin E supplements by patients with nonalcoholic steatohepatitis was associated with a greater improvement in nonalcoholic fatty liver disease activity scores and cytologic ballooning, compared with the use of pioglitazone of placebo, results from a randomized controlled trial showed.

[DatePublished] => 2012-03-04 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [1] => Array ( [ArticleID] => 406636 [Title] => Pioglitazone cuts risk of progression to diabetes [Summary] => People with impaired glucose tolerance were 81% less likely to develop type 2 diabetes over a three-year period if treated ... [DatePublished] => 2008-10-12 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [2] => Array ( [ArticleID] => 75778 [Title] => The best medicines for diabetes [Summary] => [DatePublished] => 2008-07-29 00:00:00 [ColumnID] => 134789 [Focus] => 0 [AuthorID] => 1805275 [AuthorName] => Dr. Willie T. Ong [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
PIOGLITAZONE
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 783179
                    [Title] => Initial results show NASH improved with vitamin E
                    [Summary] => 

The use of vitamin E supplements by patients with nonalcoholic steatohepatitis was associated with a greater improvement in nonalcoholic fatty liver disease activity scores and cytologic ballooning, compared with the use of pioglitazone of placebo, results from a randomized controlled trial showed.

[DatePublished] => 2012-03-04 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [1] => Array ( [ArticleID] => 406636 [Title] => Pioglitazone cuts risk of progression to diabetes [Summary] => People with impaired glucose tolerance were 81% less likely to develop type 2 diabetes over a three-year period if treated ... [DatePublished] => 2008-10-12 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [2] => Array ( [ArticleID] => 75778 [Title] => The best medicines for diabetes [Summary] => [DatePublished] => 2008-07-29 00:00:00 [ColumnID] => 134789 [Focus] => 0 [AuthorID] => 1805275 [AuthorName] => Dr. Willie T. Ong [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with